Dianthus Therapeutics Ownership 2024 | Who Owns Dianthus Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Insider Ownership

15.97%

Dianthus Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY ADVISOR SERIES VII0.02%197,696--Jan 31, 2024
FIDELITY CAPITAL TRUST0.01%92,121--Jan 31, 2024
FIDELITY SECURITIES FUND0.00%240,326--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.00%265--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%12,65010,525495.47%Dec 31, 2023
VANGUARD INDEX FUNDS0.00%175,97552,30242.29%Dec 31, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%902--Dec 31, 2023
Dimensional ETF Trust0.00%4,6954,695-Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%7,2805,319271.24%Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%740740-Feb 29, 2024
Advisors' Inner Circle Fund III0.00%3232-Jan 31, 2024
WILSHIRE MUTUAL FUNDS INC0.00%441441-Dec 31, 2023
iSHARES TRUST0.00%10,815--Feb 29, 2024

Dianthus Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 197.70K shares, compromising 0.02% of its total assets.

Dianthus Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 03, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy24,670$13.63$336.25K1,928,503
Sep 28, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy30,000$13.15$394.50K1,903,833
Sep 21, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy30,000$13.20$396.00K1,873,833
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy9,367$11.76$110.16K1,843,833
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy14,887$10.85$161.52K1,834,466

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 03, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy24,670$13.63$336.25K1,928,503
Sep 28, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy30,000$13.15$394.50K1,903,833
Sep 21, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy30,000$13.20$396.00K1,873,833
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy9,367$11.76$110.16K1,843,833
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy14,887$10.85$161.52K1,834,466

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 01, 2024Fairmount Funds Management LLCdirector-J-OtherSell58,857---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 01, 2024Fairmount Funds Management LLCdirector-J-OtherBuy58,857--2,700,691
Apr 01, 2024Fairmount Funds Management LLCdirector-J-OtherSell58,857---
Jan 26, 2024CARR EDWARDofficer CHIEF ACCOUNTING OFFICERA-AwardBuy80,000$17.88$1.43M80,000
Jan 26, 2024Veness Adam Mofficer SVP, General Counsel and Sec.A-AwardBuy110,000$17.88$1.97M110,000
Jan 26, 2024Randhawa Simratofficer CHIEF MEDICAL OFFICERA-AwardBuy120,000$17.88$2.15M120,000
Jan 26, 2024Savitz Ryanofficer CHIEF FINANCIAL OFFICERA-AwardBuy120,000$17.88$2.15M120,000
Jan 26, 2024Garcia Marinodirector, officer CEO AND PRESIDENTA-AwardBuy275,000$17.88$4.92M275,000
Jan 24, 2024MOULDER LEON O JRdirector-A-AwardBuy166,667$12.00$2.00M1,436,745
Jan 24, 2024Fairmount Funds Management LLCdirector, 10 percent owner A-AwardBuy834,334$12.00$10.01M2,762,837
Jan 24, 2024Fairmount Funds Management LLCdirector, 10 percent owner A-AwardBuy832,333-$832.33832,333
Jan 24, 2024Meng Leidirector-A-AwardBuy1,500,000$12.00$18.00M2,717,554
Jan 24, 2024Meng Leidirector-A-AwardBuy1,833,333-$1.83K1,833,333
Oct 03, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy24,670$13.63$336.25K1,928,503
Sep 28, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy30,000$13.15$394.50K1,903,833
Sep 21, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy30,000$13.20$396.00K1,873,833
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy9,367$11.76$110.16K1,843,833
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner P-PurchaseBuy14,887$10.85$161.52K1,834,466
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner A-AwardBuy6,500$11.20$72.80K6,500
Sep 13, 2023Fairmount Funds Management LLCdirector, 10 percent owner Buy---1,819,579

The last insider sell of Dianthus Therapeutics's stock was made by Fairmount Funds Management LLC on Apr 01 2024, selling 58,857 shares at - per share (valued at -). The last insider buy of DNTH was made by Fairmount Funds Management LLC on Oct 03 2023, buying 24,670 shares at $13.63 per share (worth $336.25K).

Dianthus Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202411100.00%
Q1 202410--
Q3 20236--

1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Dianthus Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q3 20235--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Dianthus Therapeutics's stocks.

DNTH Ownership FAQ